top of page
Avraham.jpg

Avraham Laban, PhD

Chief Technology Officer, Portfolio Manager

Dr. Avraham Laban (PhD), Chief Technology Officer (CTO) and Portfolio Manager at BioXL, brings extensive experience in drug development, enzyme production, and biochemical analysis to the team. He has held research and teaching positions at prestigious institutions such as MIT and Harvard, as well as in Israel. Dr. Laban has founded and managed a startup in the renewable energy sector and is a co-founder of several startups in biopharma, food-tech, and biotech. His diverse expertise positions him as a key leader in advancing innovative solutions within the biopharmaceutical landscape.

bottom of page